Renal function, protein binding and pharmacological response to diazoxide

Area of Science:

• Pharmacology
• Nephrology
• Cardiology

Background:

• Hypertension is a prevalent condition often associated with impaired renal function.
• Diazoxide is an antihypertensive medication used in emergencies.
• The protein binding of drugs can significantly influence their efficacy, especially in patients with altered physiological states.

Purpose of the Study:

• To investigate the hypotensive effect of rapid diazoxide injections in hypertensive patients with varying degrees of renal impairment.
• To explore the relationship between renal function, plasma urea levels, and the blood pressure response to diazoxide.
• To examine the protein binding characteristics of diazoxide in patients with renal failure.

Main Methods:

• Ten hypertensive patients with diverse renal function levels received rapid (10-second) intravenous injections of diazoxide.
• Measurements included mean arterial blood pressure and plasma urea concentration.
• Diazoxide protein binding was assessed in patients with and without renal failure.

Main Results:

• A significant inverse correlation was observed between plasma urea concentration and the reduction in mean arterial blood pressure.
• Diazoxide exhibited lower protein binding in patients experiencing renal failure.
• Patients with reduced renal function demonstrated a more pronounced hypotensive response to diazoxide.

Conclusions:

• Impaired renal function in hypertensive patients is associated with an enhanced blood pressure-lowering effect of diazoxide.
• Increased concentrations of unbound diazoxide in patients with renal failure are suggested as the mechanism for this augmented hypotensive effect.
• These findings highlight the importance of considering renal function when administering diazoxide for hypertensive emergencies.